Neuren Pharmaceuticals Limited’s (NEU) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Neuren Pharmaceuticals Limited is a Buy.

Neuren Pharmaceuticals Limited’s (NEU) 20-Day exponential moving average is 13.36, while Neuren Pharmaceuticals Limited’s (NEU) share price is AU$13.04, making it a Sell.

Neuren Pharmaceuticals Limited’s (NEU) 50-Day exponential moving average is 13.31, while Neuren Pharmaceuticals Limited’s (NEU) share price is AU$13.04, making it a Sell.

Neuren Pharmaceuticals Limited (NEU) Pivot Points

Feb 21, 2025, 11:19 AM

Classic

12.37

12.78

13.09

13.50

13.81

14.22

14.53

Fibonacci

12.78

13.05

13.22

13.50

13.77

13.94

14.22

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Neuren Pharmaceuticals Limited (NEU) Moving Averages

Feb 21, 2025, 11:19 AM

MA5

13.19Sell

13.20Sell

MA10

13.32Sell

13.31Sell

MA20

13.74Sell

13.36Sell

MA50

13.03Buy

13.31Sell

MA100

13.31Sell

13.78Sell

MA200

15.72Sell

15.73Sell

Neuren Pharmaceuticals Limited’s (NEU) 10-Day exponential moving average is 13.31, while Neuren Pharmaceuticals Limited’s (NEU) share price is AU$13.04, making it a Sell.

Neuren Pharmaceuticals Limited’s (NEU) 100-Day exponential moving average is 13.78, while Neuren Pharmaceuticals Limited’s (NEU) share price is AU$13.04, making it a Sell.

Neuren Pharmaceuticals Limited’s (NEU) stock price is AU$13.04 and Neuren Pharmaceuticals Limited’s (NEU) 50-day simple moving average is 13.03, creating a Buy signal.

Neuren Pharmaceuticals Limited’s (NEU) stock price is AU$13.04 and Neuren Pharmaceuticals Limited’s (NEU) 100-day simple moving average is 13.31, creating a Sell signal.

Neuren Pharmaceuticals Limited’s (NEU) stock price is AU$13.04 and Neuren Pharmaceuticals Limited’s (NEU) 200-day simple moving average is 15.72, creating a Sell signal.

Neuren Pharmaceuticals Limited (NEU) Technical Indicators

Feb 21, 2025, 11:19 AM

RSI (14)

46.23

Neutral

STOCH (9,6)

23.12

Neutral

STOCHRSI (14)

17.63

Buy

MACD (12,26)

>-0.01

Buy

ADX (14)

13.59

Buy

Williams %R

-82.14

Buy

CCI (14)

-96.46

Neutral

ATR (14)

0.57

Ultimate Oscillator

34.62

Neutral

ROC

-10.01

Sell

Neuren Pharmaceuticals Limited’s (NEU) Relative Strength Index (RSI) is 46.23, creating a Neutral signal.

Neuren Pharmaceuticals Limited’s (NEU) Trend Strength Indicator (ADX) is 13.59, creating a Buy signal.

Neuren Pharmaceuticals Limited’s (NEU) Commodity Channel Index (CCI) is -96.46, creating a Neutral signal.

Neuren Pharmaceuticals Limited’s (NEU) Price Rate of Change (ROC) is -10.01, creating a Sell signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is NEU a Buy, Hold, or Sell?

Based on NEU’s technical indicators, NEU is a Sell.

What is NEU’s RSI (14)?

NEU’s RSI (14) is 46.23, which suggests NEU is a Neutral.

What is NEU’s MACD?

NEU’s MACD is >-0.01, which suggests NEU is a Buy.

What is NEU’s 5-day moving average?

NEU’s 5-day moving average is 13.19, which suggests NEU is a Sell.

What is NEU’s 20-day moving average?

NEU 20-day moving average is 13.74, which suggests NEU is a Sell.

What is NEU’s 50-day moving average?

NEU’s 50-day moving average is 13.03, which suggests NEU is a Buy.

What is NEU’s 200-day moving average?

NEU’s 200-day moving average is 15.72, which suggests NEU is a Sell.

What is NEU’s Williams % R (14)?

NEU’s Williams % R (14) is -82.14, which suggests NEU is a Buy.

What is NEU’s CCI (14)?

NEU’s CCI (14) is -96.46, which suggests NEU is a Neutral.

What is the share price of Neuren Pharmaceuticals Limited?

Neuren Pharmaceuticals Limited's share price is N/AAU$.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing